Kaushik J. Dave, Executive Vice President at ANTARES PHARMA, INC. (ATRS), sold 48,000 shares at $4.01 ($192K) on 2013-06-03, disclosed to the SEC on 2013-06-05.
Scheduled sale ($192k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |